Periscope Capital’s DA32 Life Science Tech Acquisition Corp. Class A Common Stock DALS Stock Holding History

Periscope Capital’s Portfolio DALS Stock Details DALS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1,182,558	Closed	-$12.1M	–	698
2023 Q2	$12.1M	Buy	1,182,558 +72,756	+7%	+$742K	0.94%	19
2023 Q1	$11.2M	Buy	+1,109,802	New	+$11.2M	0.52%	61

Periscope Capital's DALS Position: Q3 2023 in Review

Periscope Capital sold out of DA32 Life Science Tech Acquisition Corp. Class A Common Stock (DALS) in Q3 2023, closing a stake of 1,182,558 shares — an estimated $12.1M sold.

Periscope Capital first reported a position in DALS in Q1 2023 and held it in 2 quarters. The position peaked at $12.1M in Q2 2023. 0 funds tracked by Wall St. Rank hold DALS as of Q3 2023.

Periscope Capital reported no remaining DA32 Life Science Tech Acquisition Corp. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
Periscope Capital sold 1,182,558 DA32 Life Science Tech Acquisition Corp. Class A Common Stock shares in Q3 2023, an estimated $12.1M.
Periscope Capital first reported a position in DA32 Life Science Tech Acquisition Corp. Class A Common Stock in Q1 2023 and held it in 2 quarters.
Periscope Capital's DA32 Life Science Tech Acquisition Corp. Class A Common Stock position peaked at $12.1M in Q2 2023.
0 funds tracked by Wall St. Rank held DA32 Life Science Tech Acquisition Corp. Class A Common Stock as of Q3 2023.

Based on Periscope Capital's 13F filing for Q3 2023, filed 6 Nov 2023.